{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2009"],"condition":["unresectable metastatic colorectal cancer"],"disease":["Unresectable Metastatic Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2617422"],"location":["Japan"],"study_start_month":["3"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Evaluating amphiregulin in plasma for metastatic colorectal cancer treated with cetuximab based therapy","description":"Primary outcome(s): disease control rate between higher and lower amphiregulin group","dates":{"creation":"2009-03-15"},"accession":"2617422","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000001934"]}}